Edition:
United Kingdom

Cadila Healthcare Says Zydus Gets Final Nod From U.S. FDA For Clindamycin Phosphate Topical Solution


Tuesday, 17 Jul 2018 

July 17 (Reuters) - Cadila Healthcare Ltd ::SAYS ZYDUS GETS FINAL APPROVAL FROM U.S. FDA FOR CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP.DRUG USED TO TREAT ACNE, HELPS TO DECREASE THE NUMBER OF ACNE LESIONS.DRUG TO BE MANUFACTURED AT TOPICAL MANUFACTURING FACILITY AT AHMEDABAD.